Article Information
vol. 52 no. 4
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 18, 2018
- Accepted August 13, 2018
- Published online October 18, 2018.
Article Versions
- previous version (August 23, 2018 - 07:38).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©ERS 2018. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Author Information
- Eugene R. Bleecker1,
- Michael E. Wechsler2,
- J. Mark FitzGerald3,
- Andrew Menzies-Gow4,
- Yanping Wu5,
- Ian Hirsch5,
- Mitchell Goldman5,
- Paul Newbold6 and
- James G. Zangrilli5
- 1Divisions of Pharmacogenomics and Genetics, Genomics and Precision Medicine, University of Arizona College of Medicine, Tucson, AZ, USA
- 2National Jewish Health, Denver, CO, USA
- 3Centre for Heart and Lung Health, The Lung Centre, Vancouver General Hospital, UBC Institute for Heart and Lung Health, Vancouver, BC, Canada
- 4Dept of Asthma and Allergy, Royal Brompton Hospital, London, UK
- 5AstraZeneca, Gaithersburg, MD, USA
- 6MedImmune LLC, Gaithersburg, MD, USA
- Eugene R. Bleecker, Division of Genetics, Genomics and Precision Medicine, University of Arizona Dept of Medicine, Division of Pharmacogenomics, University of Arizona Center for Applied Genetics and Genomics Medicine, 1230 North Cherry Avenue, Suite 251, PO Box 210242, Tucson, AZ 85721, USA. E-mail: erbleecker{at}email.arizona.edu
Funding
AstraZeneca